Nitrosylcobalamin Potentiates the Anti-Neoplastic Effects of Chemotherapeutic Agents via Suppression of Survival Signaling

Joseph A. Bauer, Joseph A. Lupica, Heidi Szugye et al. · 2007

Read Nitrosylcobalamin Potentiates the Anti-Neoplastic Effects of Chemotherapeutic Agents via Suppression of Survival Signaling by Joseph A. Bauer, Joseph A. Lupica, Heidi Szugye et al. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001313.txt.

Description

Nitrosylcobalamin is a drug built on vitamin B12 that delivers nitric oxide preferentially to tumor cells, which display extra B12 receptors. Joseph Bauer and colleagues tested it alongside standard chemotherapy agents, in a 2007 PLOS ONE article. The compound induces apoptosis through one pathway and inhibits survival signaling in cancer cells.

The authors report that nitrosylcobalamin potentiates the anti-neoplastic effects of chemotherapeutic agents via suppression of survival signaling. Two attacks are better than one if they do not simply add toxicity. Their study explores whether the B12-based pro-drug makes established drugs work harder against tumors.

Catalog record

CREATORJoseph A. Bauer, Joseph A. Lupica, Heidi Szugye et al.
YEAR2007
COLLECTIONPAPERS
FORMATTXT
FILE SIZE51 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001313

Browse the full library · About the Tower of Babel